Skip to main navigation Skip to search Skip to main content

Clinical presentation and management of snakebite envenoming in northern Ghana

  • Leslie Mawuli Aglanu
  • , John Humphrey Amuasi
  • , Ibrahim Kwaku Duah
  • , Melvin Katey Agbogbatey
  • , Jonathan Steinhorst
  • , Austin Gideon Adobasom-Anane
  • , Zakari Bukari
  • , Tia Joseph Azabu
  • , Benno Kreuels
  • , David Griffith Lalloo
  • , Ymkje Stienstra
  • University of Groningen
  • Kumasi Centre for Collaborative Research in Tropical Medicine (KCCR)
  • Bernhard Nocht Institute for Tropical Medicine
  • Kwame Nkrumah University of Science and Technology
  • University of Hamburg
  • North East Region
  • Wa Municipal Hospital
  • Kamuzu University of Health Sciences

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Abstract

BACKGROUND: Snakebite envenoming is among the top five emergency health conditions in northern Ghana. Among the four genera of snake species classified to be of highest medical importance, species with haemotoxic venom are responsible for about 90% of all snakebite case presentations in the region. However, there is a dearth of clinical data on signs and symptoms of envenoming, treatment practices and health outcomes. We examined the signs and symptoms of envenoming and clinical management practices at referral hospitals in northern Ghana. 

METHODS: Medical records of patients reporting on account of snakebite between 2016 and 2020 at the Wa Municipal Hospital in the Upper West region and the Baptist Medical Centre in the North East region of Ghana were reviewed. Demographic characteristics, patients' clinical data and management practices were analysed and evaluated taking into consideration the national standard treatment guideline. 

RESULTS: A total of 2,684 records of patients reporting on account of snakebite were accessed at both health facilities over the five-year period. 91% of the patients were admitted to the ward. Swelling, severe pain and bleeding were the most common clinical signs upon presentation. A total of 1,670 (64.7%) of all the patients tested had at least one abnormal blood clotting result suggesting haemotoxicity. Antivenom was administered to 84.3% of the patients. Antibiotics were administered to 70.5% with amoxicillin with clavulanic acid, flucloxacillin and metronidazole accounting for 59.2% of all antibiotics administered. The recorded case-fatality rate was 1.9%. 

CONCLUSION: The annual hospital attendance rate on account of snakebite to the Wa Municipal Hospital and the Baptist Medical Centre is estimated at 55 persons per 100,000 population per year. Mortality was low, with antivenom available to most of the patients. More evidence is needed on the indication and dosing of antivenom and to improve appropriate ancillary care.

Original languageEnglish
Article numbere0013820
Pages (from-to)e0013820
JournalPLoS Neglected Tropical Diseases
Volume19
Issue number12
DOIs
Publication statusPublished - 12 Dec 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Clinical presentation and management of snakebite envenoming in northern Ghana'. Together they form a unique fingerprint.

Cite this